UC Davis Raked In $845 Million In Research Funding In 2018-19
Source: Sacramento Business Journal, Felicia Alvarez
Photo: Prasant Mohapatra is UC Davis’ vice chancellor of research. The university brought in $845 million in research funding in its 2018-19 fiscal year. (COURTESY OF UC DAVIS)
The University of California Davis brought in its second-highest level of research funding ever, in its last fiscal year, with a total of $845 million in funding.
The total amount of research funding landed just $1.2 million below the previous year’s all-time high of $846.7 million. The 2018-2019 total represents 4,519 awards, according to the university.
Federal government funding represented about 56% of all research funding awarded to UC Davis, or about $473 million. Funding increases were noted year-over-year in the grants that the university received from the National Institutes of Health, the U.S. Department of Health and Human Services and the National Science Foundation.
The second-highest amount of funding came from the state, including $124.8 million in grants. The university also received $74.3 million from private industry, the majority of which was from the pharmaceutical, medical and food industries, according to spokesman AJ Cheline. He added that a significant portion of those dollars go towards funding clinical studies.
“The establishment of UC Davis as a top research university is demonstrated by its continued success in attracting a high level of external funding,” said Prasant Mohapatra, vice chancellor for research, in a press statement. “Our researchers impact planetary health and social advancements through their cutting-edge research.”
Health continues to be one of the largest sources of research dollars. The largest funding award, about $34.9 million, went to the university’s California Animal Health and Foot Safety Laboratory System, which provides diagnoses for animal diseases. Another large award for $18 million was earmarked for a project to provide surveillance for pathogens that can spread between humans and animals.
“Going forward, growth in multidisciplinary and new research areas addressing global challenges will be a key focus of our research enterprise,” said Mohapatra. “We will also expand our efforts on technology transfer and commercialization to enhance our continued impact on the local economy.”